Epstein Secrets

anufacturing 5% Bristol Myers 9.0 Information {including software publishers} 4% Eli Lilly 8.0 Finance, insurance, real estate, rental and leasing 4% DuPont 17 Transportation equipment manufacturing 3% Pepsi Co, Inc. 14 Management of companies and enterprises 3% Intel 62 All other industries 2% Coca-Cola

965, Company Repatriated Amount ($bn) Selected Items, by Selected Major and Minor Industry of the Parent Pfizer 355 Corporation, Tax Years 2004-2006 Merck 15.9 Industry % of Repatriated Cash Dividends Hewlett Packard 145 Pharmaceutical and medicine manufacturing 29% Johnson & Johnson 107 Computer and el

ive In Late-Stage Trials <https://vvwvv.wsj.corn/articles/astrazeneca-oxford-covid-19-vaccine-up-to-90-effective-in-late-stage-trials- 11606116047> DuPont's Up-And-Down History Shaped Biden's Views On Business <https://www.wsj.com/articles/duponts-up- and-down-history-shaped-bidens-views-on-business-116

ting an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behind." Some Countries Face "Immense" Stakes With AstraZeneca's Vaccine. Bloomberg

GSA Sends Letter To Biden Making Resources Available For Transition AstraZeneca-Oxford Covid-19 Vaccine Up To 90% Effective In Late-Stage Trials DuPont's Up-And-Down History Shaped Biden's Views On Business Turkey First-Timers: Thanksgiving Rookies Face Trying To Cook The Feast Solo Amid Coronavi

ing an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behind." Some Countries Face "Immense" Stakes With AstraZeneca's Vaccine. Bloomberg (1

i Aramco Saudi Arabia Skandinaviska Enskilda Sweden Banken (SEB) International Food Policy Research Institute (IFPRI) China Reform Foundation DuPont Wipro Technologies INSEAD Harvard University Sandvik AB ZBI Europe LLC USA People's Republic of China USA India Singapore USA Sweden Uni

iness School Google Inc. USA USA Germany Switzerland USA USA World Economic Forum Annual Meeting EFTA_R1_02105175 EFTA02707407 President, Merck Vaccines MSD USA Julie Louise Gerberding Mikhail Gerchuk Mohammad Abdullah Al Gergawi David R. Gergen Valery Gergiev Natalia Germanova Ola

y athenahealth), Nuvelo (NASDAQ: NUVO), Sapient Health Network (acquired by WebMD), Spotfire (acquired by Tibco Software), and Combichem (acquired by DuPont). He also led our investment in, and was a board observer at, Audax Health (acquired by UnitedHealth/Optum). Immediately prior to joining Sprout, Phi

) and Tioga. He was previously on the boards of Intarcia Therapuetics (now currently a Board observer), Sirna Therapeutics (NASDAQ: RNAI, acquired by Merck in 2006 for $1.1 billion), where he served as Chairman; Oriel Therapeutics (acquired by Novartis in 2010), where he served as Executive Chairman, and